The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper

• DOI: 10.1186/s12882-020-02177-x
• Publication Date: 2020-11-26T12:03:40Z
• Authors: Samuel A. Headley; Donna J. Chapman; Michael J. Germain; Elizabeth E. Evans; Jasmin Hutchinson; Karen L. Madsen; Talat Alp Ikizler; Emily M. Miele; Kristyn Kirton; Elizabeth O’Neill; Allen Cornelius; Brian Martin; Bradley Nindl; Nosratola D. Vaziri
• Keywords: Adult; Kidney Disease; Clinical Sciences; Clinical Trials and Supportive Activities; Renal and urogenital; Inflammatory markers; Uremic toxins; 610; Clinical sciences; Nursing; Cardiovascular; Zea mays; Kidney Failure; Study Protocol; 03 medical and health sciences; Double-Blind Method; Clinical Research; Health services and systems; Humans; Chronic; Exercise; Aged; Randomized Controlled Trials as Topic; Inflammation; Analysis of Variance; 0303 health sciences; Biomedical and Clinical Sciences; Prevention; Resistant starch; Evaluation of treatments and therapeutic interventions; Resistant Starch; Urology & Nephrology; Middle Aged; Diseases of the genitourinary system. Urology; Gastrointestinal Microbiome; 3. Good health; Oxidative Stress; Oxidative stress; 6.1 Pharmaceuticals; Kidney Failure, Chronic; RC870-923; Amylose; Biomarkers

AbstractBackgroundChronic kidney disease (CKD) is characterized by dysbiosis, elevated levels of uremic toxins, systemic inflammation, and increased markers of oxidative stress. These factors lead to an increased risk of cardiovascular disease (CVD) which is common among CKD patients. Supplementation with high amylose maize resistant starch type 2 (RS-2) can change the composition of the gut microbiota, and reduce markers of inflammation and oxidative stress in patients with end-stage renal disease. However, the impact of RS-2 supplementation has not been extensively studied in CKD patients not on dialysis. Aerobic exercise training lowers certain markers of inflammation in CKD patients. Whether combining aerobic training along with RS-2 supplementation has an additive effect on the aforementioned biomarkers in predialysis CKD patients has not been previously investigated.MethodsThe study is being conducted as a 16-week, double-blind, placebo controlled, parallel arm, randomized controlled trial. Sixty stage 3–4 CKD patients (ages of 30–75 years) are being randomized to one of four groups: RS-2 & usual care, RS-2 & aerobic exercise, placebo (cornstarch) & usual care and placebo & exercise. Patients attend four testing sessions: Two baseline (BL) sessions with follow up visits 8 (wk8) and 16 weeks (wk16) later. Fasting blood samples, resting brachial and central blood pressures, and arterial stiffness are collected at BL, wk8 and wk16. A stool sample is collected for analysis of microbial composition and peak oxygen uptake is assessed at BL and wk16. Blood samples will be assayed for p-cresyl sulphate and indoxyl sulphate, c-reactive protein, tumor necrosis factor α, interleukin 6, interleukin 10, monocyte chemoattractant protein 1, malondialdehyde, 8-isoprostanes F2a, endothelin-1 and nitrate/nitrite. Following BL, subjects are randomized to their group. Individuals randomized to conditions involving exercise will attend three supervised moderate intensity (55–65% peak oxygen uptake) aerobic training sessions (treadmills, bikes or elliptical machine) per week for 16 weeks.DiscussionThis study has the potential to yield information about the effect of RS-2 supplementation on key biomarkers believed to impact upon the development of CVD in patients with CKD. We are examining whether there is an additive effect of exercise training and RS-2 supplementation on these key variables.Trial registrationClinicaltrials.govTrial registration#NCT03689569.9/28/2018, retrospectively registered.